Endre søk
Begrens søket
1 - 7 of 7
RefereraExporteraLink til resultatlisten
Permanent link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Treff pr side
  • 5
  • 10
  • 20
  • 50
  • 100
  • 250
Sortering
  • Standard (Relevans)
  • Forfatter A-Ø
  • Forfatter Ø-A
  • Tittel A-Ø
  • Tittel Ø-A
  • Type publikasjon A-Ø
  • Type publikasjon Ø-A
  • Eldste først
  • Nyeste først
  • Skapad (Eldste først)
  • Skapad (Nyeste først)
  • Senast uppdaterad (Eldste først)
  • Senast uppdaterad (Nyeste først)
  • Disputationsdatum (tidligste først)
  • Disputationsdatum (siste først)
  • Standard (Relevans)
  • Forfatter A-Ø
  • Forfatter Ø-A
  • Tittel A-Ø
  • Tittel Ø-A
  • Type publikasjon A-Ø
  • Type publikasjon Ø-A
  • Eldste først
  • Nyeste først
  • Skapad (Eldste først)
  • Skapad (Nyeste først)
  • Senast uppdaterad (Eldste først)
  • Senast uppdaterad (Nyeste først)
  • Disputationsdatum (tidligste først)
  • Disputationsdatum (siste først)
Merk
Maxantalet träffar du kan exportera från sökgränssnittet är 250. Vid större uttag använd dig av utsökningar.
  • 1.
    Chalmers, J. R.
    et al.
    Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham, England..
    Simpson, E.
    Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA..
    Apfelbacher, C. J.
    Univ Regensburg, Inst Epidemiol & Prevent Med, Med Sociol, D-93053 Regensburg, Germany..
    Thomas, K. S.
    Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham, England..
    von Kobyletzki, Laura B.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013). Lund Univ, Skane Univ Hospital, Dept Dermatol, Malmo, Sweden.
    Schmitt, J.
    Univ Dresden, Ctr Lvidence Based Hlthcare, Dresden, Germany.;Tech Univ Dresden, Dept Occupat & Social Med, D-01062 Dresden, Germany..
    Singh, J. A.
    Birmingham VA Med Ctr, Med Serv, Birmingham, AL USA.;Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA..
    Svensson, A.
    Malmo Univ Hosp, Dept Dermatol & Venerol, Malmo, Sweden..
    Williams, H. C.
    Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham, England..
    Abuabara, K.
    Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA..
    Aoki, V.
    Univ Sao Paulo, Sch Med, Dept Dermatol, Sao Paulo, Brazil..
    Ardeleanu, M.
    Regeneron Pharmaceut Inc, Immunol & Inflammat, New York, NY USA..
    Awici-Rasmussen, M.
    Psoriasis & Eczema Assoc Norway, Oslo, Norway..
    Barbarot, S.
    CHU Nantes, Dept Dermatol, F-44035 Nantes 01, France..
    Berents, T. L.
    Univ Oslo, Inst Clin Med, Oslo 3, Norway.;Oslo Univ Hosp, Dept Dermatol, Oslo, Norway..
    Block, J.
    Natl Eczema Assoc, Natl Eczema Org, San Rafael, CA USA..
    Bragg, A.
    Chugai Pharma Europe Ltd, London, England..
    Burton, T.
    Clemmensen, K. K. Bjerring
    Univ Copenhagen, Bispebjerg Hosp, Dept Dermatol, Copenhagen, Denmark..
    Creswell-Melville, A.
    Soc Canadienne IEczema, Keswick, ON, Canada..
    Dinesen, M.
    LEO Pharma AS, Industriparken 55, Ballerup, Denmark..
    Drucker, A.
    Univ Hlth Nem ork, Div Dermatol, Toronto, ON, Canada..
    Eckert, L.
    Hlth Econ & Outcomes Res, Sanofi, France..
    Flohr, C.
    Guys & St Thomas Hosp NHS Fdn Trust, St Johns Inst Dermatol, London, England.;Kings Coll London, London, England..
    Garg, M.
    LEO Pharma, Copenhagen, Denmark..
    Gerbens, L. A. A.
    Univ Amsterdam, Acad Med Ctr, Dept Dermatol, Amsterdam, Netherlands..
    Graff, A. L. B.
    Natl Eczema Soc, London, England..
    Hanifin, J.
    Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA..
    Heinl, D.
    Univ Regensburg, Inst Epidemiol & Prevent Med, Med Sociol, D-93053 Regensburg, Germany..
    Humphreys, R.
    Natl Eczema Soc, London, England..
    Ishii, H. A.
    Brazilian Atop Dermatitis Assoc AADA, Sao Paulo, Brazil..
    Kataoka, Y.
    Osaka Prefectural Med Ctr Resp & Allerg Dis, Osaka, Japan..
    Leshem, Y. A.
    Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA..
    Marquort, B.
    Massuel, M. -A
    Merhand, S.
    Assoc Francaise Eczema, Redon, France..
    Mizutani, H.
    Mie Univ, Grad Sch Med, Tsu, Mie, Japan.;Mie Univ, Hosp Tsu, Tsu, Mie, Japan..
    Murota, H.
    Osaka Univ, Dept Dermatol, Osaka, Japan..
    Murrell, D. F.
    St George Hosp, Dept Dermatol, Sydney, NSW, Australia.;Univ New S Wales, Sydney, NSW, Australia..
    Nakahara, T.
    Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka, Japan..
    Nasr, I.
    Nograles, K.
    Greater New York City Area Pharmaceut, Celgene Corp, New York, NY USA..
    Ohya, Y.
    Natl Ctr Child Hlth & Dev, Dept Med Subspecialties, Div Allergy, Tokyo, Japan..
    Osterloh, I.
    Ostermed Ltd, Kent, OH USA..
    Pander, J.
    Celgene BV, Utrecht, Netherlands..
    Prinsen, C.
    Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands..
    Purkins, L.
    Ziarco Pharma Ltd, Canterbury, Kent, England..
    Ridd, M.
    Univ Bristol, Sch Social & Community Med, Bristol, Avon, England..
    Sach, T.
    Univ E Anglia, Hlth Econ Grp, Norwich, Norfolk, England..
    Schuttelaar, M. -LA.
    Shindo, S.
    Osaka Univ, Dept Dermatol, Osaka, Japan..
    Smirnova, J.
    Karlstad Univ, Dept Publ Hlth Sci, Karlstad, Sweden..
    Sulzer, A.
    Sanofi Aventis, Montpellier, France..
    Gjerde, E. Synnove
    Psoriasis & Eczema Assoc Norway, Oslo, Norway..
    Takaoka, R.
    Univ Sao Paulo, Sch Med, Dept Dermatol, Sao Paulo, Brazil..
    Talmo, H. Vestby
    Sanofi Aventis, Montpellier, France..
    Tauber, M.
    Toulouse Univ, Toulouse, France..
    Torchet, F.
    Mie Univ, Grad Sch Med, Tsu, Mie, Japan.;Mie Univ, Hosp Tsu, Tsu, Mie, Japan..
    Volke, A.
    Univ Tartu, Dept Dermatol, Tartu, Estonia..
    Wahlgren, C. -F
    Weidinger, S.
    Venereol & Allergy Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany..
    Weisshaar, E.
    Heidelberg Univ, Dept Social Med, Occupat & Environm Dermatol, Heidelberg, Germany..
    Wollenberg, A.
    Univ Munich, Dept Dermatol & Allergy, Munich, Germany..
    Yamaga, K.
    Osaka Univ, Dept Dermatol, Osaka, Japan..
    Zhao, C. Y.
    St George Hosp, Dept Dermatol, Sydney, NSW, Australia.;Univ New S Wales, Sydney, NSW, Australia..
    Spuls, P. I.
    Univ Amsterdam, Acad Med Ctr, Dept Dermatol, Amsterdam, Netherlands..
    Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)2016Inngår i: British Journal of Dermatology, ISSN 0007-0963, E-ISSN 1365-2133, Vol. 175, nr 1, s. 69-79Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    This article is a report of the fourth meeting of the Harmonising Outcome Measures for Eczema (HOME) initiative held in Malmo, Sweden on 23-24 April 2015 (HOME IV). The aim of the meeting was to achieve consensus over the preferred outcome instruments for measuring patient-reported symptoms and quality of life for the HOME core outcome set for atopic eczema (AE). Following presentations, which included data from systematic reviews, consensus discussions were held in a mixture of whole group and small group discussions. Small groups were allocated a priori to ensure representation of different stakeholders and countries. Decisions were voted on using electronic keypads. For the patient-reported symptoms, the group agreed by vote that itch, sleep loss, dryness, redness/inflamed skin and irritated skin were all considered essential aspects of AE symptoms. Many instruments for capturing patient-reported symptoms were discussed [ including the Patient-Oriented SCOring Atopic Dermatitis index, Patient-Oriented Eczema Measure (POEM), Self-Administered Eczema Area and Severity Index, Itch Severity Scale, Atopic Dermatitis Quickscore and the Nottingham Eczema Severity Score] and, by consensus, POEM was selected as the preferred instrument to measure patient-reported symptoms. Further work is needed to determine the reliability and measurement error of POEM. Further work is also required to establish the importance of pain/soreness and the importance of collecting information regarding the intensity of symptoms in addition to their frequency. Much of the discussion on quality of life concerned the Dermatology Life Quality Index and Quality of Life Index for Atopic Dermatitis; however, consensus on a preferred instrument for measuring this domain could not be reached. In summary, POEM is recommended as the HOME core outcome instrument for measuring AE symptoms.

  • 2. Chalmers, J. R.
    et al.
    Thomas, K. S.
    Apfelbacher, C.
    Williams, H. C.
    Prinsen, C. A.
    Spuls, P. I.
    Simpson, E.
    Gerbens, L. A. A.
    Boers, M.
    Barbarot, S.
    Stalder, J. F.
    Abuabara, K.
    Aoki, V.
    Ardeleanu, M.
    Armstrong, J.
    Bang, B.
    Berents, T. L.
    Burton, T.
    Butler, L.
    Chubachi, T.
    Cresswell-Melville, A.
    DeLozier, A.
    Eckert, L.
    Eichenfield, L.
    Flohr, C.
    Futamura, M.
    Gadkari, A.
    Gjerde, E. S.
    van Halewijn, K. F.
    Hawkes, C.
    Howells, L.
    Howie, L.
    Humphreys, R.
    Ishii, H. A.
    Kataoka, Y.
    Katayama, I.
    Kouwenhoven, W.
    Langan, S. M.
    Leshem, Y. A.
    Merhand, S.
    Mina-Osorio, P.
    Murota, H.
    Nakahara, T.
    Nunes, F. P.
    Nygaard, U.
    Nygardas, M.
    Ohya, Y.
    Ono, E.
    Rehbinder, E.
    Rogers, N. K.
    Romeijn, G. L. E.
    Schuttelaar, M. L. A.
    Sears, A. V.
    Simpson, M. A.
    Singh, J. A.
    Srour, J.
    Stuart, B.
    Svensson, A.
    Talmo, G.
    Talmo, H.
    Teixeira, H. D.
    Thyssen, J. P.
    Todd, G.
    Torchet, F.
    Volke, A.
    von Kobyletzki, Laura B.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013). Karolinska Institutet; Lund University; University Hospital Schleswig-Holstein, Kiel, Germany.
    Weisshaar, E.
    Wollenberg, A.
    Zaniboni, M.
    Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)2018Inngår i: British Journal of Dermatology, ISSN 0007-0963, E-ISSN 1365-2133, Vol. 178, nr 5, s. E332-E341Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    This is the report from the fifth meeting of the Harmonising Outcome Measures for Eczema initiative (HOME V). The meeting was held on 12-14 June 2017 in Nantes, France, with 81 participants. The main aims of the meeting were (i) to achieve consensus over the definition of the core domain of long-term control and how to measure it and (ii) to prioritize future areas of research for the measurement of the core domain of quality of life (QoL) in children. Moderated whole-group and small-group consensus discussions were informed by presentations of qualitative studies, systematic reviews and validation studies. Small-group allocations were performed a priori to ensure that each group included different stakeholders from a variety of geographical regions. Anonymous whole-group voting was carried out using handheld electronic voting pads according to pre-defined consensus rules. It was agreed by consensus that the long-term control domain should include signs, symptoms, quality of life and a patient global instrument. The group agreed that itch intensity should be measured when assessing long-term control of eczema in addition to the frequency of itch captured by the symptoms domain. There was no recommendation of an instrument for the core outcome domain of quality of life in children, but existing instruments were assessed for face validity and feasibility, and future work that will facilitate the recommendation of an instrument was agreed upon.

  • 3.
    Schmitt, J.
    et al.
    Tech Univ Dresden, Ctr Evidence Based Healthcare, D-01062 Dresden, Germany..
    Langan, S.
    London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England..
    Deckert, S.
    Tech Univ Dresden, Ctr Evidence Based Healthcare, D-01062 Dresden, Germany..
    Svensson, A.
    Lund Univ, Inst Clin Sci, Dept Dermatol, Malmo, Sweden..
    von Kobyletzki, Laura B
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper. Lund Univ, Skne Univ Hosp, Dept Dermatol, Inst Clin Res Malmo, Malmo, Sweden.;Karlstad Univ, Dept Publ Hlth Sci, Karlstad, Sweden..
    Thomas, K. S.
    Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham NG7 2RD, England..
    Spuls, P.
    Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands..
    How to measure clinical signs of atopic dermatitis?: A systematic review and recommendation2014Inngår i: British Journal of Dermatology, ISSN 0007-0963, E-ISSN 1365-2133, Vol. 170, nr 6, s. E40-E41Artikkel i tidsskrift (Annet vitenskapelig)
  • 4.
    von Kobyletzki, Laura B.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013). Lund Univ, Skne Univ Hosp, Dept Dermatol, Inst Clin Res Malmo, Malmo, Sweden.;Karlstad Univ, Dept Publ Hlth Sci, Karlstad, Sweden..
    Atopic eczema and nonatopic eczema show the same pattern in an adolescent general population2015Inngår i: British Journal of Dermatology, ISSN 0007-0963, E-ISSN 1365-2133, Vol. 173, nr 4, s. 889-889Artikkel i tidsskrift (Fagfellevurdert)
  • 5.
    von Kobyletzki, Laura B.
    et al.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013). Lund Univ, Skne Univ Hosp, Dept Dermatol, Inst Clin Res Malmo, Malmo, Sweden.;Karlstad Univ, Dept Publ Hlth Sci, Karlstad, Sweden..
    Beckman, Linda
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    Smirnova, J
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    Smeeth, L
    London School of Hygiene and Tropical Medicine.
    Williams, H C
    Centre of Evidence Based Dermatology, University of Nottingham.
    McKee, M
    London School of Hygiene and Tropical Medicine.
    Abuabara, K
    University of California, San Francisco, USA.
    Langan, S M
    London School of Hygiene and Tropical Medicine, UK.
    Eczema and educational attainment: A systematic review2017Inngår i: British Journal of Dermatology, ISSN 0007-0963, E-ISSN 1365-2133, Vol. 177, nr 3, s. e47-e49Artikkel, forskningsoversikt (Fagfellevurdert)
    Abstract [en]

    Eczema (syn. atopic dermatitis or atopic eczema) accounts for the largest global burden of disability due to skin disease (1) . Eczema affects up to 20% of children (1) , and is associated with impaired quality of life (QoL) of a similar magnitude to cancer and epilepsy. Yet, although eczema is common in children, little is known about long-term outcomes such as educational attainment (EA) of those affected. This article is protected by copyright. All rights reserved.

  • 6.
    von Kobyletzki, Laura B
    et al.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper. Lund Univ, Skne Univ Hosp, Dept Dermatol, Inst Clin Res Malmo, Malmo, Sweden.;Karlstad Univ, Dept Publ Hlth Sci, Karlstad, Sweden..
    Svensson, A.
    Lund Univ, Skane Univ Hosp, Dept Dermatol, D-93053 Lund, Sweden..
    Apfelbacher, C.
    Univ Regensburg, Inst Epidemiol & Prevent Med, Regensburg, Germany..
    Schmitt, J.
    Tech Univ Dresden, Ctr Evidence Based Healthcare, Univ Klinikum Carl Gustav Carus, Dresden, Germany..
    Which factors predict remission of infant atopic dermatitis?: A systematic review2014Inngår i: British Journal of Dermatology, ISSN 0007-0963, E-ISSN 1365-2133, Vol. 170, nr 6, s. E52-E53Artikkel i tidsskrift (Annet vitenskapelig)
  • 7.
    von Kobyletzki, Laura B
    et al.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper. Lund Univ, Skne Univ Hosp, Dept Dermatol, Inst Clin Res Malmo, Malmo, Sweden.;Karlstad Univ, Dept Publ Hlth Sci, Karlstad, Sweden..
    Thomas, K.
    Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham NG7 2RD, England..
    Schmitt, J.
    Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Ctr Evidence Based Healthcare, Dresden, Germany..
    Chalmers, J.
    Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham NG7 2RD, England..
    Deckert, S.
    Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Ctr Evidence Based Healthcare, Dresden, Germany..
    Aoki, V.
    Univ Sao Paulo, Sch Med, Dept Dermatol, Sao Paulo, Brazil..
    Svensson, A.
    Lund Univ, Skane Univ Hosp, Dept Dermatol, S-22100 Lund, Sweden..
    Eczema signs and symptoms: what is important to patients?2014Inngår i: British Journal of Dermatology, ISSN 0007-0963, E-ISSN 1365-2133, Vol. 170, nr 6, s. E11-E11Artikkel i tidsskrift (Annet vitenskapelig)
1 - 7 of 7
RefereraExporteraLink til resultatlisten
Permanent link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf